Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Vence L. Bonham, Jr, JD
Researcher Senior Advisor
NHGRI Director on Genomics
and Health Disparities
Building 31, Room B1B37G
31 Center Dr, MSC 2070
Bethesda, Maryland, United States
Vence Bonham received his bachelor of Arts from James Madison College at Michigan State University and his juris doctor degree from the Moritz College of Law at the Ohio State University. Mr. Bonham was a fellow in the American Association of Medical Colleges Health Services Research Fellowship Program. Mr. Bonham was a faculty member at Michigan State University in the Colleges of Medicine and Law. Since 2003, Mr. Bonham has served as an associate investigator in the National Human Genome Research Institute (NHGRI) within the Division of Intramural Research’s Social and Behavioral Research Branch. He leads the Health Disparities Genomics Unit, which conducts research that evaluates approaches to integrating new genomic knowledge and precision medicine into clinical settings without exacerbating inequities in healthcare delivery.
His research focuses primarily on the social influences of new genomic knowledge, particularly in communities of color. He studies how genomics influences the use of the constructs of race and ethnicity in biomedical research and clinical care and the role of genomics in health inequities.
Mr. Bonham also serves as the senior advisor to the NHGRI director on genomics and health disparities.
Representative Publications:
Screening student athletes for sickle cell trait–a social and clinical experiment
Sickle cell disease related pain: crisis and conflict
+myBinderRelated Content
-
Brenda Martin, CPNP-PCBrenda Martin is a pediatric nurse pract...
-
WHATZ DA COUNTWDC on SCT has dedicated his Organizatio...
-
George Atweh, MDGeorge Atweh, MD, is a professor and div...
-
California Institute For Regenerative Medicine Awards City Of Hope $5.74 Million For Severe Sickle Cell Disease Clin...The California Institute for Regenerativ...
-
Global Blood Therapeutics Receives EMA PRIME Designation for GBT440 for the Treatment of Sickle Cell Disease (SCD)GBT440 is First Potential Treatment for ...
-
Integration of neuropsychology services in a sickle cell clinic and subsequent healthcare use for pain crisesObjective: Growing literature has docum...
-
PCORI Board Approves $18 Million for Research on Sickle Cell DiseaseThe Patient-Centered Outcomes Research I...
